Literature DB >> 16882590

Infectious causes of death in patients with rheumatoid arthritis: an autopsy study.

R Koivuniemi1, M Leirisalo-Repo, R Suomalainen, H Piirainen, L Paimela.   

Abstract

OBJECTIVE: To study mortality from infections and accuracy of pre-mortem diagnoses in patients with rheumatoid arthritis (RA) autopsied during a 40-year period.
METHODS: We investigated infectious causes of death, findings at autopsy, and clinicians' estimation of cause of death in 369 consecutively autopsied RA and 371 autopsied non-RA patients with same sex, age at death, and year of autopsy. We also compiled clinical features of RA patients from medical records available and examined the association between these and infectious causes of death.
RESULTS: Deaths from any infection were more frequent in RA (36%) than in non-RA (26%) patients. In both groups, respiratory and urinary tract infections were the most common infectious causes of death. More RA patients died from urinary tract infections than non-RA patients. In approximately half of the patients in both groups, infection as a cause of death was unrecognized before death, with no major change occurring over the 40-year study period.
CONCLUSIONS: Infections, especially respiratory and urinary tract infections, are frequent causes of death in RA patients. The high proportion of undiscovered infections as a cause of death highlights the diagnostic difficulty. With a decreasing number of autopsies being performed at present, greater numbers of infections may be under-reported.

Entities:  

Mesh:

Year:  2006        PMID: 16882590     DOI: 10.1080/03009740600556258

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  5 in total

1.  Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.

Authors:  Mónica Bogas; Pedro Machado; Ana Filipa Mourão; Lúcia Costa; Maria José Santos; João Eurico Fonseca; José António P Silva; Helena Canhão
Journal:  Clin Rheumatol       Date:  2010-02-08       Impact factor: 2.980

2.  All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists.

Authors:  Loreto Carmona; Miguel Angel Descalzo; Eva Perez-Pampin; Dolores Ruiz-Montesinos; Alba Erra; Tatiana Cobo; Juan J Gómez-Reino
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

3.  Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period.

Authors:  R Koivuniemi; L Paimela; R Suomalainen; H Piirainen; M Karesoja; T Helve; M Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

4.  Messages from the morgue to rheumatology: from Chagas disease to giant cell arteritis.

Authors:  Frank A Wollheim
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

5.  HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis.

Authors:  Jin Kyun Park; Joo-Yun Byun; Ji Ah Park; Yu-Yon Kim; Ye Ji Lee; Jeong In Oh; Sun Young Jang; Young Hoon Kim; Yeong Wook Song; Jeewoong Son; Kwee Hyun Suh; Young-Mi Lee; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2016-04-18       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.